| Literature DB >> 33313961 |
Johannes Karl Maria Fakler1, Alexander Brand2, Christian Lycke2, Christina Pempe2, Mohamed Ghanem2, Andreas Roth2, Georg Osterhoff2, Ulrich Josef Albert Spiegl2, Andreas Höch2, Dirk Zajonz2,3,4.
Abstract
PURPOSE: Hemiarthroplasty is widely accepted as the treatment of choice in elderly patients with a displaced intracapsular femoral neck fracture. Intraoperative greater trochanteric fractures thwart this successful procedure, resulting in prolonged recovery, inferior outcome, and increased risk of revision surgery. Hence, this study analyzed factors potentially associated with an increased risk for intraoperative greater trochanteric fracture.Entities:
Keywords: Femoral neck fracture; Greater trochanteric fracture; Hemiarthroplasty; Periprosthetic fracture
Mesh:
Year: 2020 PMID: 33313961 PMCID: PMC9192455 DOI: 10.1007/s00068-020-01549-0
Source DB: PubMed Journal: Eur J Trauma Emerg Surg ISSN: 1863-9933 Impact factor: 2.374
Fig. 1Anual case load and patient characteristics during study period
Patient-related factors associated with risk of intraoperative greater trochanteric fracture (GTF)
| Controls | GTFx | ||
|---|---|---|---|
| Age (years) | 82.4 ± 8.6 | 81.1 ± 10.0 | 0.471 |
| Female sex | 357 (75%) | 24 (71%) | 0.684 |
| BMI | 24.4 (22.0–27.0) | 23.5 (22.0–26.8) | 0.546 |
| Platelet inhibitors | 157 (33%) | 9 (27%) | 0.460 |
| Oral anticoagulants | 84 (18%) | 7 (21%) | 0.817 |
| Warfarin | 44 (9%) | 5 (15%) | 0.358 |
| NOAKs | 40 (8%) | 2 (6%) | 0.759 |
| Diabetes | 129 (27%) | 7 (21%) | 0.472 |
| Smoking | 58 (12%) | 1 (3%) | 0.160 |
| Oral glucocorticoids | 29 (6%) | 0 (0%) | 0.246 |
| CRP (mg/l) | 5.6 (1.6–24.7) | 7.7 (1.9–28.0) | 0.622 |
| Leucocyte count (exp 9/l) | 10.2 (8.0–13.2) | 11.4 (8.6–15.1) | 0.149 |
| 25OH D3 (ng/ml) | 8.0 (5.0–13.1) | 5.2 (4.0–13.1) | 0.194 |
| Creatinine (µmol/l) | 80.0 (64.0–104.0) | 77.5 (64.0–106.5) | 0.770 |
| Hemoglobin (mmol/l) | 7.7 (6.9–8.4) | 7.7 (6.8–8.4) | 0.878 |
| Prothrombin time (%) | 96 (82–106) | 86.5 (68.8–101.5) | 0.046 |
| ASA 3 and 4 | 352 (74%) | 27 (79%) | 0.547 |
Values are given as mean (± standard deviation), median (IQR) or absolute numbers and percentage. BMI body mass index, NOAKs non-vitamin K-dependent oral anticoagulants, CRP c-reactive protein, 25OH D3 25-hydroxy vitamin D3
Surgical and perioperative factors associated with risk of intraoperative greater trochanteric fracture (GTF)
| Controls | GTFx | ||
|---|---|---|---|
| Preoperative time (h) | 26 (16–42) | 19 (9–30) | 0.006* |
| Duration surgery (min)* | 71 (57–84) | 75 (61–92) | 0.142 |
| Cemented | 430 (90%) | 33 (97%) | 0.235 |
| Surgery on call | 91 (19.0%) | 6 (17.6%) | 1.000 |
| Attending surgeon | 359 (75%) | 24 (71%) | 0.683 |
| Hip arthroplasty surgeon (HAS) | 181 (38%) | 9 (27%) | 0.203 |
| Established center of arthroplasty | 148 (31%) | 17 (50%) | 0.024* |
Values are given as median (IQR) or absolute numbers and percentage, * p< 0.05
Postoperative parameters and early complications
| Controls | GTFx | ||
|---|---|---|---|
| Length of stay (LOS) | 10.0 (8.0–14.0) | 12.5 (9.9–16.5) | 0.009* |
| 30-day mortality | 43 (9.0%) | 2 (5.9%) | 0.757 |
| Revision surgery due to hematoma/seroma | 12 (2.5%) | 3 (8.8%) | 0.070 |
| Revision surgery due to early deep infection | 20 (4.2%) | 6 (17.6%) | 0.005* |
Values are given as median (IQR) or absolute numbers and percentage, * p< 0.05